Abbott Japan Spins Off New Drug Biz, Establishes New Firm “AbbVie”

November 6, 2012
As part of a global realignment of its US parent, Abbott Laboratories, Abbott Japan has spun off its proprietary pharmaceuticals business, centering on innovative drugs, by transferring the operations to AbbVie G.K., a new company it set up earlier this...read more